Immun Globg(Igg)/Malt/Iga Ov50
Brand name: Octagam
Rank #130 of 500 drugs by total cost
$129.5M
Total Cost
9,657
Total Claims
$129.5M
Total Cost
303
Prescribers
$13K
Cost per Claim
183
Beneficiaries
9,786
30-Day Fills
$428K
Avg Cost/Provider
32
Avg Claims/Provider
About Immun Globg(Igg)/Malt/Iga Ov50
Immun Globg(Igg)/Malt/Iga Ov50 (sold as Octagam) was prescribed 9,657 times by 303 Medicare Part D providers in 2023, costing the program $129.5M. At $13K per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 127 | Teriflunomide (Aubagio) | $131.9M | 18,010 |
| 128 | Umeclidinium Bromide (Incruse Ellipta) | $131.6M | 290,677 |
| 129 | Tiotropium Br/Olodaterol Hcl (Stiolto Respimat) | $130.3M | 201,233 |
| 130 | Immun Globg(Igg)/Malt/Iga Ov50 (Octagam) | $129.5M | 9,657 |
| 131 | Pregabalin (Pregabalin) | $124.3M | 2,696,923 |
| 132 | Dronedarone Hcl (Multaq) | $123.4M | 98,156 |
| 133 | Brimonidine Tartrate/Timolol (Brimonidine Tartrate-Timolol) | $122.0M | 361,001 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology